Mega Lifesciences Public Company Limited Reports Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2020
November 12, 2020 at 05:29 am EST
Share
Mega Lifesciences Public Company Limited reported consolidated earnings results for the third quarter and nine months ended September 30, 2020. For the quarter, total income was THB 3,390.1 million against THB 2,864.7 million a year ago. Reported net profit was THB 342.0 million against THB 282.1 million a year ago. Basic earnings per share were THB 0.39 against THB 0.32 a year ago.
For nine months, total income was THB 9,119.2 million against THB 8,116.6 million a year ago. Reported net profit was THB 965.4 million against THB 756.2 million a year ago. Basic earnings per share were THB 1.11 against THB 0.87 a year ago.
Mega Lifesciences Public Company Limited is engaged in manufacturing, marketing, selling and distributing quality pharmaceutical, nutraceutical products and Fast-Moving Consumer Goods (FMCG). Its segments include Maxxcare distribution business, Mega We Care branded products business, and original equipment manufacturer (OEM) business. The Maxxcare distribution business markets, sells and distributes various branded prescription pharmaceutical products, OTC and FMCG products. Its services include warehouse management, collections, including assuming the liability for bad debts, and value-added services. Its Mega We Care branded products business develops, manufactures, markets and sells its own brand of nutraceutical products, prescription pharmaceutical products and OTC products. Mega We Care branded products are sold in a total of 35 countries around the world. Its manufacturing facilities in Thailand and Australia accept various production orders from third-party customers.
MEGA LIFESCIENCES 
